What's New

11 May 2022

At the meeting of 12 April 2022 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
seizure 37/2022 38/2022
malignant neoplasm of the thyroid gland 39/2022 40/2022
malignant neoplasm of the larynx 41/2022 42/2022
morbid obesity 43/2022 44/2022
sudden unexplained death 45/2022 46/2022

These SOPs revoke the SOPs previously determined for these conditions.

Determined New Statements of Principles (SOPs) for:

Condition SOPs
thoracic outlet syndrome 47/2022 48/2022

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
diabetes mellitus 49/2022 50/2022
hypogonadism 51/2022 52/2022
hypopituitarism 53/2022 54/2022
sensorineural hearing loss 55/2022 56/2022
immune thrombocytopaenia 57/2022 58/2022
acute lymphoblastic leukaemia/lymphoblastic lymphoma 59/2022

The above SOPs take effect from 30 May 2022.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
epilepsy Intention to remove one or more factors August 2022
periodic limb movement disorder Intention to remove one or more factors August 2022
steatohepatitis Intention to remove one or more factors August 2022

Completed Investigations

The above determinations conclude the previously advertised investigations into:

Note:

  • The investigation concerning 'epileptic seizure' has resulted in the determination of Statements of Principles concerning seizure.

The above investigation notices appear in the Government Notices Gazette of 10 May 2022.